This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
FDA.Statement of Andrew C. von Eschenbach, M.D. Commissioner of Food and Drugs: Food and Drug Administration: before the Committee on Oversight and Government Reform, United States House of Representatives. Internet Document: [17 pages], 6 Jun 2007. Available from: URL: http://www.oversight.house.gov
About this article
Cite this article
The US FDA has requested the manufacturers of rosiglitazone [Avandia] and pioglitazone [Actos] to add a boxed warning. React. Wkly. 1157, 2 (2007). https://doi.org/10.2165/00128415-200711570-00004
- Public Health
- Heart Failure
- Congestive Heart Failure